Berlin – Since the beginning of 2024, several European countries have reported unusually high numbers of infections with the human parvovirus B19 (B19V), the pathogen that causes rubella (Transfusion 2024; DOI: 10.1111/trf.18032). Germany reached a
Sydney – A new comprehensive analysis of the effect of glucagon-like peptide-1 (GLP-1) receptor agonists on renal and cardiovascular outcomes shows they provide significant benefits to people with and without diabetes. As researchers led by
medicine Wednesday, December 4, 2024 Seattle – The frequent wildfires in California are associated with an increased risk of dementia for the population. According to a study in JAMA Neurology (2024; DOI: 10.1001/jamaneurol.2024.4058), the fine
2000 | Prof. Dr. Zrenner 1998 | Prof. Dr. Heimann 1996 | Prof. Dr. Seiler 1994 | Prof. Dr. Bonhoeffer 1992 | Prof. Lütjen-Drecoll 1990 | Prof. Remé 1988 | Prof. Hockwin 1986 | Dr.
/picture alliance, Jan Woitas Berlin – The cross-party group motion in the Bundestag to revise abortion regulations has already been signed by 327 MPs, according to those supporting it. SPD parliamentary group leader Rolf Mützenich
medicine Tuesday, December 3, 2024 Changsha – In gout patients with stage 3 chronic kidney disease (CKD), serum uric acid levels can be reduced to below 6 mg/dL. This is not associated with an increased
medicine Tuesday, December 3, 2024 Galway – People with the risk factors of high blood pressure, atrial fibrillation or smoking not only have an increased risk of stroke, they also have more severe strokes than
Stockholm – Long-term use of antihypertensives, cholesterol-lowering drugs and oral anticoagulants was associated with a reduced risk of developing dementia in old age in a population-based case-control study from Sweden. For… [weiter lesen] #Study #Cardiovascular
Boston – Children who were exposed to elevated concentrations of inflammatory cytokines in their mother’s womb had poorer performance test results in primary school age in a long-term study and began to show cognitive decline
medicine Monday, December 2, 2024 Berlin/Mannheim – Psilocybin improves symptoms in patients with treatment-resistant depression over a week compared to a placebo. However, the therapeutic effect decreases over an observation period of 6 weeks. Lea